<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37059887</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>168</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.</ArticleTitle><Pagination><StartPage>140</StartPage><MedlinePgn>140</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">140</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-023-05759-w</ELocationID><Abstract><AbstractText>The success of the global polio eradication initiative is threatened by the genetic instability of the oral polio vaccine, which can result in the emergence of pathogenic vaccine-derived polioviruses following prolonged replication in the guts of individuals with primary immune deficiencies or in communities with low vaccination coverage. Through environmental surveillance, circulating vaccine-derived poliovirus type 2 was detected in Uganda in the absence of detection by acute flaccid paralysis (AFP) surveillance. This underscores the sensitivity of environmental surveillance and emphasizes its usefulness in supplementing AFP surveillance for poliovirus infections in the race towards global polio eradication.</AbstractText><CopyrightInformation>Â© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tushabe</LastName><ForeName>Phionah</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0729-5505</Identifier><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda. ptushabe@uvri.go.ug.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bwogi</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eliku</LastName><ForeName>James Peter</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aine</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birungi</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaizi</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakabazzi</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabaliisa</LastName><ForeName>Theopista</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turyahabwe</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namuwulya</LastName><ForeName>Prossy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanteza</LastName><ForeName>Mary Bridget</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukenya</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanyesigye</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Water and Sewerage Corporation, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katushabe</LastName><ForeName>Edson</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>World Health Organization, Uganda Country Office, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampeire</LastName><ForeName>Immaculate</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ministry of Health Uganda, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kisakye</LastName><ForeName>Annet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization, Uganda Country Office, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakamutumaho</LastName><ForeName>Barnabas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byabamazima</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>WHO Inter-Country Support Team Office for Eastern and Southern Africa (IST/ESA), Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>MC_UU_00033/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no relevant financial or non-financial interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>10</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37059887</ArticleId><ArticleId IdType="pmc">PMC10104764</ArticleId><ArticleId IdType="doi">10.1007/s00705-023-05759-w</ArticleId><ArticleId IdType="pii">10.1007/s00705-023-05759-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, Knowles NJ et al (2017) ICTV Virus Taxonomy Profile: Picornaviridae. J Gen Virol [Internet]. ;98:2421â2. Available from: https://microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.000911</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns C, Diop O, Sutter R, Kew O (2014) Vaccine-derived polioviruses. J Infect Dis [Internet]. ;210(Supp 1):S283-93. Available from: https://pubmed.ncbi.nlm.nih.gov/25316847/</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovi T, Shulman LM, Van Der Avoort H, Deshpande J, Roivainen M, De Gourville EM et al (2012) Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect [Internet]. ;140(1):1â13. Available from: http://www.polioeradication.org/Portals/0/Document/Financing/FRR_EN_A4.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">21849095</ArticleId></ArticleIdList></Reference><Reference><Citation>Asghar H, Diop OM, Weldegebriel G, Malik F, Shetty S, Bassioni L, El, et al. Environmental surveillance for polioviruses in the global polio eradication initiative. J Infect Dis. 2014;210(Suppl 1):S294â303. doi: 10.1093/infdis/jiu384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu384</ArticleId><ArticleId IdType="pmc">PMC10578309</ArticleId><ArticleId IdType="pubmed">25316848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroiss SJ, Ahmadzai M, Ahmed J, Alam MM, Chabot-Couture G, Famulare M, et al. Assessing the sensitivity of the polio environmental surveillance system. PLoS ONE. 2018;13(12):1â18. doi: 10.1371/journal.pone.0208336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208336</ArticleId><ArticleId IdType="pmc">PMC6310268</ArticleId><ArticleId IdType="pubmed">30592720</ArticleId></ArticleIdList></Reference><Reference><Citation>OâReilly KM, Verity R, Durry E, Asghar H, Sharif S, Zaidi SZ et al (2018) Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: An observational study. BMC Infect Dis [Internet]. ;18(176). Available from: https://10.0.4.162/s12879-018-3070-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899327</ArticleId><ArticleId IdType="pubmed">29653509</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2003) Guidelines for environmental surveillance of poliovirus circulation. Geneva</Citation></Reference><Reference><Citation>Matrajt G, Naughton B, Bandyopadhyay AS, Meschke JS. A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus. Clin Infect Dis. 2018;67(suppl1):S90âS97. doi: 10.1093/cid/ciy638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy638</ArticleId><ArticleId IdType="pmc">PMC6206110</ArticleId><ArticleId IdType="pubmed">30376094</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Polio laboratory manual [Internet]. 4th ed. WHO Library (2004) 157 p. Available from: http://apps.who.int//iris/handle/10665/68762</Citation></Reference><Reference><Citation>Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, et al. Diagnostic Assay Development for Poliovirus Eradication. J Clin Microbiol. 2018;56(2):e01624âe01617. doi: 10.1128/JCM.01624-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tushabe P, Howard W, Bwogi J, Birungi M, Eliku JP, Kakooza P, et al. Molecular characterization of non-polio enteroviruses isolated from acute flaccid paralysis patients in Uganda. J Med Virol. 2021;93(8):4720â4728. doi: 10.1002/jmv.26804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26804</ArticleId><ArticleId IdType="pmc">PMC9787851</ArticleId><ArticleId IdType="pubmed">33458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L, et al. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods. 2011;174(1â2):128â130. doi: 10.1016/j.jviromet.2011.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.03.020</ArticleId><ArticleId IdType="pubmed">21440569</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman MM, Jorba J, Henderson E, Diop OM, Shaukat S, TraorÃ© MA, et al. Update on Vaccine-Derived Poliovirus Outbreaks â Worldwide, January 2020âJune 2021. MMWR Morb Mortal Wkly Rep. 2021;70(49):1691â1699. doi: 10.15585/mmwr.mm7049a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7049a1</ArticleId><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Campagnoli R, De L, Kew O (2008) Calibration of Multiple Poliovirus Molecular Clocks Covering an Extended Evolutionary Range. J Virol [Internet]. ;82(9):4429â4440. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293050/pdf/2354-07.pdf</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2293050</ArticleId><ArticleId IdType="pubmed">18287242</ArticleId></ArticleIdList></Reference><Reference><Citation>Voorman A, Lyons H, Bennette C, Kovacs S, Makam JK, Vertefeuille F et al (2022) J,. Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine. Vaccine [Internet]. ; Available from: 10.1016/j.vaccine.2022.03.013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10973941</ArticleId><ArticleId IdType="pubmed">35339308</ArticleId></ArticleIdList></Reference><Reference><Citation>Uganda, WHO and UNICEF estimates of immunization coverage : 2021 revision [Internet]. [cited 2022 Dec 19]. Available from: https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=&amp;ved=2ahUKEwjcluOFtIX8AhUD-YUKHbecDk0QFnoECAkQAQ&amp;url=https%3A%2F%2Fdata.unicef.org%2Fwp-content%2Fuploads%2F2022%2F07%2Fuga.pdf&amp;usg=AOvVaw0uvwFIkkyaMC6IhRVI9FHW</Citation></Reference><Reference><Citation>Hill M, Bandyopadhyay AS, Pollard AJ (2022) Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use. Lancet (London, England) [Internet]. Sep 3 [cited 2022 Sep 22];400(10354):713â5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35988575</Citation><ArticleIdList><ArticleId IdType="pubmed">35988575</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. World Health Organisation extranet dataset [Internet]. 2022 [cited 2022 Sep 12]. Available from: https://extranet.who.int/polis/public/CaseCount.aspx</Citation></Reference><Reference><Citation>Burki T (2019) Vaccine-derived poliovirus cases exceed wild types. Lancet Infect Dis [Internet]. ;19(2):140. Available from: 10.1016/S1473-3099(19)30012-X</Citation><ArticleIdList><ArticleId IdType="pubmed">31876508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YA, Chen X, Kunasekaran M, Rahman B, MacIntyre CR Global epidemiology of vaccine-derived poliovirus 2016â2021: A descriptive analysis and retrospective case-control study. eClinicalMedicine [Internet]. 2022 Aug 1 [cited 2022 Sep 8];50. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS25895370(22)00238-3/fulltext#.Yxmvp6mOuaQ.mendeley</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240990</ArticleId><ArticleId IdType="pubmed">35784443</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom JK, Obodai E, Boateng G, Diamenu S, Attiku K, Avevor P, et al. Detection of vaccine-derived poliovirus circulation by environmental surveillance in the absence of clinical cases. Hum Vaccines Immunother. 2021;17(7):2117â2124. doi: 10.1080/21645515.2020.1852009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1852009</ArticleId><ArticleId IdType="pmc">PMC8189041</ArticleId><ArticleId IdType="pubmed">33517832</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Vaccine-derived poliovirus type 2 (VDPV2) detected in environmental samples in London, UK [Internet]. 2022 [cited 2022 Aug 8]. Available from: https://www.who.int/news/item/22-06-2022-vaccine-derived-poliovirus-type-2-(vdpv2)-detected-in-environmental-samples-in-london--uk</Citation></Reference><Reference><Citation>Esteves-Jaramillo A, Estivariz CF, Pearanda S, Richardson VL, Reyna J, Coronel DL, et al. Detection of vaccine-derived polioviruses in Mexico using environmental surveillance. J Infect Dis. 2014;210(suppl1):S315âS323. doi: 10.1093/infdis/jiu183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu183</ArticleId><ArticleId IdType="pmc">PMC10389690</ArticleId><ArticleId IdType="pubmed">25316850</ArticleId></ArticleIdList></Reference><Reference><Citation>The Nucleic Acid Observatory Consortium. A Global Nucleic Acid Observatory for Biodefense and Planetary Health The Nucleic Acid Observatory Consortium 1 [Internet]. Available from: https://arxiv.org/pdf/2108.02678.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>